179 related articles for article (PubMed ID: 24322039)
1. Axillary basal cell carcinoma--a rare form of a frequent kind of carcinoma.
Costescu M; Coman OA; Tampa M; Tudose I; Coman L; Georgescu SR
Rom J Morphol Embryol; 2013; 54(3 Suppl):851-6. PubMed ID: 24322039
[TBL] [Abstract][Full Text] [Related]
2. Ki67 as a biologic marker of basal cell carcinoma: a retrospective study.
Kramer E; Herman O; Frand J; Leibou L; Schreiber L; Vaknine H
Isr Med Assoc J; 2014 Apr; 16(4):229-32. PubMed ID: 24834759
[TBL] [Abstract][Full Text] [Related]
3. Basal cell carcinoma of the axilla: review of the world literature.
Cohen PR
Am J Clin Dermatol; 2014 Apr; 15(2):95-100. PubMed ID: 24567258
[TBL] [Abstract][Full Text] [Related]
4. Calcifications associated with basal cell carcinoma: prevalence, characteristics, and correlations.
Slodkowska EA; Cribier B; Peltre B; Jones DM; Carlson JA
Am J Dermatopathol; 2010 Aug; 32(6):557-64. PubMed ID: 20489568
[TBL] [Abstract][Full Text] [Related]
5. Axillary basal cell carcinoma: case report and literature review.
Lin CT; Chen SG; Chen TM; Chang SC
Acta Dermatovenerol Croat; 2011; 19(2):107-9. PubMed ID: 21703158
[TBL] [Abstract][Full Text] [Related]
6. Aggressive basal cell carcinoma: presentation, pathogenesis, and management.
Walling HW; Fosko SW; Geraminejad PA; Whitaker DC; Arpey CJ
Cancer Metastasis Rev; 2004; 23(3-4):389-402. PubMed ID: 15197337
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
[TBL] [Abstract][Full Text] [Related]
8. Expression of metallothionein I/II and Ki-67 antigen in various histological types of basal cell carcinoma.
Bieniek A; Pula B; Piotrowska A; Podhorska-Okolow M; Salwa A; Koziol M; Dziegiel P
Folia Histochem Cytobiol; 2012 Oct; 50(3):352-7. PubMed ID: 23042264
[TBL] [Abstract][Full Text] [Related]
9. Basosquamous cell carcinoma: a survey of 76 patients and a comparative analysis of basal cell carcinomas and squamous cell carcinomas.
Betti R; Crosti C; Ghiozzi S; Cerri A; Moneghini L; Menni S
Eur J Dermatol; 2013; 23(1):83-6. PubMed ID: 23238332
[TBL] [Abstract][Full Text] [Related]
10. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
[TBL] [Abstract][Full Text] [Related]
11. [Histologic risk factors of basal cell carcinoma of the face, about 184 cases].
Wavreille O; Martin De Lassalle E; Wavreille G; Mortier L; Martinot Duquennoy V
Ann Chir Plast Esthet; 2012 Dec; 57(6):542-8. PubMed ID: 22534511
[TBL] [Abstract][Full Text] [Related]
12. Granular cell basal cell carcinoma: report of a case and review of the literature.
Claassen SL; Royer MC; Rush WL
Am J Dermatopathol; 2014 Jul; 36(7):e121-4. PubMed ID: 24247582
[TBL] [Abstract][Full Text] [Related]
13. Ber-EP4 is a useful marker for follicular germinative cell differentiation of cutaneous epithelial neoplasms.
Ansai S; Takayama R; Kimura T; Kawana S
J Dermatol; 2012 Aug; 39(8):688-92. PubMed ID: 22300237
[TBL] [Abstract][Full Text] [Related]
14. [Immunomorphological features of cutaneous basal-cell carcinoma].
Chuprov IN
Vopr Onkol; 2008; 54(6):715-9. PubMed ID: 19241845
[TBL] [Abstract][Full Text] [Related]
15. Variations in clinical presentation of basal cell carcinoma.
Buljan M; Bulat V; Situm M; Mihić LL; Stanić-Duktaj S
Acta Clin Croat; 2008 Mar; 47(1):25-30. PubMed ID: 18714644
[TBL] [Abstract][Full Text] [Related]
16. Idiopathic basal cell carcinoma in children.
Alcalay J; Ben-Amitai D; Alkalay R
J Drugs Dermatol; 2008 May; 7(5):479-81. PubMed ID: 18505143
[TBL] [Abstract][Full Text] [Related]
17. [Metastatic Basal cell carcinoma in the axilla: reconstruction with a lateral pectoral island flap].
Martorell-Calatayud A; Sanz-Motilva V; Candelas D; Sanchez-Carpintero I; Delgado Y; Ruiz-Rodríguez R
Actas Dermosifiliogr; 2011 Jan; 102(1):53-7. PubMed ID: 21315862
[TBL] [Abstract][Full Text] [Related]
18. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
[TBL] [Abstract][Full Text] [Related]
19. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
[TBL] [Abstract][Full Text] [Related]
20. Expressions of p53, cyclinD1 and histopathological features in basal cell carcinomas.
Koseoglu RD; Sezer E; Eyibilen A; Aladag I; Etikan I
J Cutan Pathol; 2009 Sep; 36(9):958-65. PubMed ID: 19187116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
